TP53 and diffuse large B-cell lymphoma: p63 expression was associated with significantly better OS and PFS in patients with WT-TP53 and IPI scores >2 (Fig 5A, B) and in ABC-DLBCL patients with WT-TP53 (Fig 5C, D), and favorable trends in patients with MUT-p53+ GCB-DLBCL (Fig 5G, H).